No Detail Found!

Remission of Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia in a Cat Treated with Corticotherapy

Author(s)
B Agulla Department of Animal Medicine and Surgery, College of Veterinary Medicine, Complutense University of Madrid,Avda. Puerta de Hierro s/n, 28040, Madrid,Spain
D Díaz-Regañón Department of Animal Medicine and Surgery, College of Veterinary Medicine, Complutense University of Madrid,Avda. Puerta de Hierro s/n, 28040, Madrid,Spain
M García-Sancho Department of Animal Medicine and Surgery, College of Veterinary Medicine, Complutense University of Madrid,Avda. Puerta de Hierro s/n, 28040, Madrid,Spain
F Rodríguez-Franco Department of Animal Medicine and Surgery, College of Veterinary Medicine, Complutense University of Madrid,Avda. Puerta de Hierro s/n, 28040, Madrid,Spain
A Villaescusa Department of Animal Medicine and Surgery, College of Veterinary Medicine, Complutense University of Madrid,Avda. Puerta de Hierro s/n, 28040, Madrid,Spain
A Rodríguez-Bertos Department of Animal Medicine and Surgery, College of Veterinary Medicine, Complutense University of Madrid,Avda. Puerta de Hierro s/n, 28040, Madrid,Spain ; VISAVET Health Surveillance Centre, Complutense University of Madrid,28040 Madrid,Spain
C Pérez Díaz Department of Animal Medicine and Surgery, College of Veterinary Medicine, Complutense University of Madrid,Avda. Puerta de Hierro s/n, 28040, Madrid,Spain
A Sainz Department of Animal Medicine and Surgery, College of Veterinary Medicine, Complutense University of Madrid,Avda. Puerta de Hierro s/n, 28040, Madrid,Spain
Abstract
Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia (FGESF) is a rare clinical entity of unknown aetiology. The most defended hypothesis refers to a genetic alteration in the immune response regulation, which results in an exacerbated eosinophilic inflammation. The proposed treatment for FGESF includes immunosuppressive drugs and surgical resection of the lesion. A 2- and- a- halfyear old neutered, male, Chartreux cat was diagnosed with FGESF with the presence of a mass in the first duodenal flexure, which was surgically removed and recurred 8 months post-surgery. After using an immunosuppressive treatment for one year, the macroscopic disappearance of the lesion and the complete remission of the clinical signs were achieved. To our knowledge, this is the first description of disappearance of a FGESF lesion located in the gastrointestinal tract after prolonged immunosuppressive treatment. This clinical report highlights the possibility to treat this new feline disease with the exclusive use of immunosuppressive drugs.
Publication Details
Page(s) 309-312
Published Journal: Pakistan Veterinary Journal, Volume: 41, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
CAT, Immunosuppressive treatment, mass, Feline Gastrointestinal, Eosinophilic Sclerosing, Fibroplasia, Gastrointestinal tract, Remission
0

Citations

0

Downloads

35

Views